LY3537982 Evidence: Trial Results and Peer-Reviewed Publications

Hipa.ai Research · Source: PubMed & ClinicalTrials.gov / AACT · Last updated: May 20, 2026

The clinical evidence base for LY3537982 comprises 1 peer-reviewed publications across 1 journals, 0 pivotal-trial primary-outcome rows reported to ClinicalTrials.gov, spanning indications including Carcinoma, Non-Small-Cell Lung. Most recent publication: SUNRAY-01 trial protocol: an innovative study design of olomorasib and pembrolizumab with or without chemotherapy in KRAS G12C NSCLC., Future Oncol, 2026.

Top peer-reviewed publications

Curated set of pivotal-trial result papers and recent publications in high-tier journals.

SUNRAY-01 trial protocol: an innovative study design of olomorasib and pembrolizumab with or without chemotherapy in KRAS G12C NSCLC.
Peters S, Hochmair M, Arbour KC, et al. · Future Oncol · 2026
PubMed: PMID 41940628 · NCT06119581 (SUNRAY-01) · Carcinoma, Non-Small-Cell Lung

Publications by year

2026–2026: 1 publications.

2026

Publications by indication

Carcinoma, Non-Small-Cell Lung (1)

SUNRAY-01 trial protocol: an innovative study design of olomorasib and pembrolizumab with or without chemotherapy in KRAS G12C NSCLC.
Future Oncol · 2026 · PMID 41940628 · NCT06119581

Publications by journal

Future Oncol1 paper

All LY3537982 publications (1)

2026 (1 paper)

SUNRAY-01 trial protocol: an innovative study design of olomorasib and pembrolizumab with or without chemotherapy in KRAS G12C NSCLC.
Peters S, Hochmair M, Arbour KC, et al. · Future Oncol · 2026 · Derived
PubMed: PMID 41940628 · NCT06119581 (SUNRAY-01) · Carcinoma, Non-Small-Cell Lung

Sources and methodology

Publications: ctgov.study_references (PubMed PMIDs auto-attached by ClinicalTrials.gov to each trial), reference types RESULT, DERIVED, and BACKGROUND.
Per-arm outcome values: ctgov.outcome_measurements joined to ctgov.design_outcomes where outcome_type = 'PRIMARY', restricted to phase PHASE3 and PHASE2/PHASE3.
Publication metadata (title, journal, year, authors): PubMed E-utilities efetch.fcgi
Data freshness: Wed, 20 May 2026 23:58:10 GMT.

This page summarizes published evidence for general reference and does not constitute medical advice. For clinical decisions, consult the linked primary publications and your healthcare provider. Data sourced from PubMed and the ClinicalTrials.gov / AACT database maintained by the Clinical Trials Transformation Initiative (CTTI).